PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway

The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?

(2018) Teizo Yoshimura   Cellular & Molecular Immunology

Looking for New Inhibitors for the Epidermal Growth Factor Receptor

(2018) Riccardo Concu et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2

(2018) Hui Shen et al.   Cell Death & Disease

Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy

(2018) Tatsuya Nagano et al.   Cells

Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling

(2017) Sung-Ying Huang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

CCL2 expression correlates with Snail expression and affects the prognosis of patients with gastric cancer

(2017) Jia Zhang et al.   PATHOLOGY RESEARCH AND PRACTICE

FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling

(2016) Xuguang Yang et al.   CANCER RESEARCH

CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR

(2016) J Hou et al.   ONCOGENE

6-Shogaol, an Active Constituent of Dietary Ginger, Impairs Cancer Development and Lung Metastasis by Inhibiting the Secretion of CC-Chemokine Ligand 2 (CCL2) in Tumor-Associated Dendritic Cells

(2015) Ya-Ling Hsu et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages

(2015) Takanori Kitamura et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The quest to overcome resistance to EGFR-targeted therapies in cancer

(2013) Curtis R Chong et al.   NATURE MEDICINE

Inhibition of STAT Signalling in Bladder Cancer by Diindolylmethane - Relevance to Cell Adhesion, Migration and Proliferation

(2012) Yiyang Sun et al.   CURRENT CANCER DRUG TARGETS

Gallbladder cancer: Can newer insights improve the outcome?

(2011) Usha Dutta   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Intersectin 1 Enhances Cbl Ubiquitylation of Epidermal Growth Factor Receptor through Regulation of Sprouty2-Cbl Interaction

(2011) M. N. Okur et al.   MOLECULAR AND CELLULAR BIOLOGY

Transcriptome Profiling of Whole Blood Cells Identifies PLEK2 and C1QB in Human Melanoma

(2011) Yuchun Luo et al.   PLoS One

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases

(2009) Jasmine V. Abella et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

EMT, the cytoskeleton, and cancer cell invasion

(2009) Mahmut Yilmaz et al.   CANCER AND METASTASIS REVIEWS

CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis

(2009) Jian Zhang et al.   CYTOKINE & GROWTH FACTOR REVIEWS

A review of the surgical strategies for the management of gallbladder carcinoma based on T stage and growth type of the tumour

(2009) C. Pilgrim et al.   EJSO

Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer

(2009) Tetsuya Mitsudomi et al.   FEBS Journal

Ubc4/5 and c-Cbl Continue to Ubiquitinate EGF Receptor after Internalization to Facilitate Polyubiquitination and Degradation

(2008) Kyohei Umebayashi et al.   MOLECULAR BIOLOGY OF THE CELL